RICHARDSON, Texas, April 14 /PRNewswire/ -- Zyvex today announced financial results for its fiscal 2005 first quarter. The Texas Company continues its business gains with total revenues for the first quarter totaling $2.0 million -- a 240 percent increase over the same period in 2004. International sales accounted for 11 percent of the quarter's revenue. "I continue to be extremely pleased with the financial and operational performance of the company during the last two years," stated Zyvex CFO Timothy M. Gilmore. "Our NanoSolve(TM) Materials and NanoWorks(R) Tools continue to drive these positive results, and we are making good progress in broadening both product lines to continue this growth." Founded in 1997, Zyvex reported its first revenues in 2001, grossing $150,000. Company revenues grew to $1.2 million in 2002, $4.3 million in 2003, and $8.6 million in 2004. International sales, new to the company during 2004, accounted for 10 percent of 2004's revenue. Gilmore anticipates that the company will achieve cash-flow break-even by Q1 2006, and become bottom-line profitable by the end of 2006. The company has customers in the Aerospace/Defense, Healthcare/Medical, and Electronics/Semiconductor industries. 2004 saw a 225 percent increase in customers, and a 75 percent increase in partnerships and alliances. Zyvex also has numerous key alliances with industry leaders, including Easton Sports, FEI Company, Frost & Sullivan, MANCEF, MIT's Institute for Soldier Nanotechnologies, and many others. Zyvex has worldwide sales representation in China, France, Germany, Italy, Japan, Korea, Malaysia, Poland, Singapore, Switzerland, Taiwan, Thailand, the United Kingdom, and Vietnam through alliances with Keithley Instruments, Inc., Caltron, Pte., and L.O.T.-Oriel. About the Company Zyvex Corporation, based in Richardson, Texas, is the first molecular nanotechnology company. Zyvex's vision is to be the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing. Zyvex commercializes nanotechnology to address real-world applications with high growth potential. Zyvex carries its scientific breakthroughs into key commercial applications in the area of materials, tools, and structures.
SOURCE Zyvex Corporation